BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8236280)

  • 1. Recombinant yeast in drug metabolism.
    Renaud JP; Peyronneau MA; Urban P; Truan G; Cullin C; Pompon D; Beaune P; Mansuy D
    Toxicology; 1993 Oct; 82(1-3):39-52. PubMed ID: 8236280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
    Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
    Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme.
    Renaud JP; Cullin C; Pompon D; Beaune P; Mansuy D
    Eur J Biochem; 1990 Dec; 194(3):889-96. PubMed ID: 2269307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
    Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
    Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
    Inui H; Maeda A; Ohkawa H
    Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
    Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
    Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity of ergopeptides for cytochromes P450 3A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine.
    Peyronneau MA; Delaforge M; Riviere R; Renaud JP; Mansuy D
    Eur J Biochem; 1994 Aug; 223(3):947-56. PubMed ID: 8055971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5.
    Truan G; Cullin C; Reisdorf P; Urban P; Pompon D
    Gene; 1993 Mar; 125(1):49-55. PubMed ID: 8449412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P450 redox enzymes in the white rot fungus Phanerochaete chrysosporium: gene transcription, heterologous expression, and activity analysis on the purified proteins.
    Subramanian V; Doddapaneni H; Syed K; Yadav JS
    Curr Microbiol; 2010 Oct; 61(4):306-14. PubMed ID: 20221604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
    Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
    Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
    Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a yeast system that stably expresses human cytochrome P450 reductase: application for the study of drug metabolism of cytochrome P450s in vitro.
    Cheng J; Wan DF; Gu JR; Gong Y; Yang SL; Hao DC; Yang L
    Protein Expr Purif; 2006 Jun; 47(2):467-76. PubMed ID: 16434211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4.
    Lee CA; Kadwell SH; Kost TA; Serabjit-Singh CJ
    Arch Biochem Biophys; 1995 May; 319(1):157-67. PubMed ID: 7771780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximizing the expression of mammalian cytochrome P-450 monooxygenase activities in yeast cells.
    Urban P; Cullin C; Pompon D
    Biochimie; 1990; 72(6-7):463-72. PubMed ID: 2124149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
    Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
    Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of house fly (Musca domestica) cytochrome P450 CYP6D1 in yeast (Saccharomyces cerevisiae).
    Smith FF; Scott JG
    Insect Biochem Mol Biol; 1997 Dec; 27(12):999-1006. PubMed ID: 9569642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetically engineered P450 monooxygenase: construction of the functional fused enzyme between rat cytochrome P450c and NADPH-cytochrome P450 reductase.
    Murakami H; Yabusaki Y; Sakaki T; Shibata M; Ohkawa H
    DNA; 1987 Jun; 6(3):189-97. PubMed ID: 3109864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expression system and the differences in the marker activities.
    Nakajima M; Tane K; Nakamura S; Shimada N; Yamazaki H; Yokoi T
    J Pharm Sci; 2002 Apr; 91(4):952-63. PubMed ID: 11948533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression in yeast of three allelic cDNAs coding for human liver P-450 3A4. Different stabilities, binding properties and catalytic activities of the yeast-produced enzymes.
    Peyronneau MA; Renaud JP; Jaouen M; Urban P; Cullin C; Pompon D; Mansuy D
    Eur J Biochem; 1993 Dec; 218(2):355-61. PubMed ID: 8269924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.